Cargando…
A cat with myelodysplastic syndrome by administration of the methylation inhibitor Azacytidine
A 5-year-old female cat with nonregenerative anemia and thrombocytopenia was diagnosed with myelodysplastic syndromes (MDS), since peripheral blood and bone marrow (BM) examination revealed various dysplasias and a blast ratio of 19%. Chemotherapy with azacytidine (AZA; 70–35 mg/m(2), 3–5 days, thre...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810310/ https://www.ncbi.nlm.nih.gov/pubmed/34866071 http://dx.doi.org/10.1292/jvms.20-0352 |